Royal Bank of Canada’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18M | Buy |
+150,000
| New | +$17.3M | ﹤0.01% | 1516 |
|
|
2025
Q3 | – | Sell |
-350,000
| Closed | -$27.7M | – | 7361 |
|
|
2025
Q2 | $27.7M | Sell |
350,000
-125,000
| -26% | -$9.94M | 0.01% | 1308 |
|
|
2025
Q1 | $42.6M | Buy |
+475,000
| New | +$44.3M | 0.01% | 868 |
|
|
2024
Q4 | – | Sell |
-60,000
| Closed | -$6.81M | – | 7110 |
|
|
2024
Q3 | $6.81M | Buy |
+60,000
| New | +$7.13M | ﹤0.01% | 2043 |
|
|
2023
Q2 | – | Sell |
-229,200
| Closed | -$24.4M | – | 7507 |
|
|
2023
Q1 | $24.4M | Sell |
229,200
-228,900
| -50% | -$24.7M | 0.01% | 1023 |
|
|
2022
Q4 | $50.8M | Buy |
458,100
+178,100
| +64% | +$18.2M | 0.01% | 679 |
|
|
2022
Q3 | $24.1M | Sell |
280,000
-168,700
| -38% | -$15.1M | 0.01% | 964 |
|
|
2022
Q2 | $40.9M | Buy |
448,700
+391,200
| +680% | +$34.7M | 0.01% | 739 |
|
|
2022
Q1 | $4.72M | Sell |
57,500
-66,700
| -54% | -$5.26M | ﹤0.01% | 2305 |
|
|
2021
Q4 | $9.52M | Sell |
124,200
-800
| -0.6% | -$63.7K | ﹤0.01% | 1920 |
|
|
2021
Q3 | $9.39M | Buy |
+125,000
| New | +$9.51M | ﹤0.01% | 1858 |
|
|
2021
Q2 | – | Sell |
-10,480
| Closed | -$771K | – | 7609 |
|
|
2021
Q1 | $771K | Sell |
10,480
-834,418
| -99% | -$61.6M | ﹤0.01% | 3819 |
|
|
2020
Q4 | $65.9M | Buy |
844,898
+806,227
| +2,085% | +$61.7M | 0.02% | 595 |
|
|
2020
Q3 | $3.06M | Sell |
38,671
-218,089
| -85% | -$17.1M | ﹤0.01% | 2347 |
|
|
2020
Q2 | $18.9M | Sell |
256,760
-112,974
| -31% | -$8.5M | 0.01% | 1065 |
|
|
2020
Q1 | $27.1M | Sell |
369,734
-241,460
| -40% | -$19M | 0.01% | 750 |
|
|
2019
Q4 | $53M | Buy |
611,194
+472,334
| +340% | +$38.8M | 0.02% | 603 |
|
|
2019
Q3 | $11.2M | Sell |
138,860
-16,663
| -11% | -$1.34M | ﹤0.01% | 1487 |
|
|
2019
Q2 | $12.4M | Buy |
155,523
+81,849
| +111% | +$6.27M | 0.01% | 1411 |
|
|
2019
Q1 | $5.85M | Sell |
73,674
-8,070
| -10% | -$604K | ﹤0.01% | 1905 |
|
|
2018
Q4 | $5.96M | Buy |
81,744
+8,384
| +11% | +$592K | ﹤0.01% | 1850 |
|
|
2018
Q3 | $4.97M | Sell |
73,360
-70,426
| -49% | -$4.49M | ﹤0.01% | 2130 |
|
|
2018
Q2 | $8.33M | Sell |
143,786
-219,136
| -60% | -$12.4M | ﹤0.01% | 1657 |
|
|
2018
Q1 | $18.9M | Sell |
362,922
-30,916
| -8% | -$1.67M | 0.01% | 1127 |
|
|
2017
Q4 | $21.1M | Buy |
393,838
+325,718
| +478% | +$18.1M | 0.01% | 1102 |
|
|
2017
Q3 | $4.16M | Sell |
68,120
-5,240
| -7% | -$318K | ﹤0.01% | 2116 |
|
|
2017
Q2 | $4.49M | Sell |
73,360
-150,388
| -67% | -$9.15M | ﹤0.01% | 2021 |
|
|
2017
Q1 | $13.6M | Buy |
223,748
+39,090
| +21% | +$2.37M | 0.01% | 1296 |
|
|
2016
Q4 | $10.4M | Buy |
184,658
+21,380
| +13% | +$1.25M | 0.01% | 1481 |
|
|
2016
Q3 | $9.72M | Sell |
163,278
-277,720
| -63% | -$16.2M | 0.01% | 1495 |
|
|
2016
Q2 | $24.2M | Sell |
440,998
-5,869
| -1% | -$312K | 0.01% | 833 |
|
|
2016
Q1 | $22.6M | Sell |
446,867
-273,843
| -38% | -$13.4M | 0.01% | 857 |
|
|
2015
Q4 | $36.3M | Buy |
720,710
+579,859
| +412% | +$29.2M | 0.02% | 594 |
|
|
2015
Q3 | $6.64M | Buy |
140,851
+36,051
| +34% | +$1.92M | 0.01% | 1417 |
|
|
2015
Q2 | $5.69M | Hold |
104,800
| – | – | ﹤0.01% | 1527 |
|
|
2015
Q1 | $5.75M | Sell |
104,800
-209,600
| -67% | -$11.9M | ﹤0.01% | 1515 |
|
|
2014
Q4 | $17M | Sell |
314,400
-219,242
| -41% | -$12.2M | 0.01% | 939 |
|
|
2014
Q3 | $30.2M | Buy |
533,642
+271,642
| +104% | +$15.3M | 0.02% | 593 |
|
|
2014
Q2 | $14.5M | Buy |
262,000
+188,640
| +257% | +$10.3M | 0.01% | 990 |
|
|
2014
Q1 | $3.97M | Sell |
73,360
-67,072
| -48% | -$3.47M | ﹤0.01% | 1743 |
|
|
2013
Q4 | $6.71M | Buy |
140,432
+120,520
| +605% | +$5.51M | ﹤0.01% | 1456 |
|
|
2013
Q3 | $905K | Sell |
19,912
-180,046
| -90% | -$8.22M | ﹤0.01% | 2838 |
|
|
2013
Q2 | $8.86M | Buy |
+199,958
| New | +$8.93M | 0.01% | 1101 |
|
Other funds holding MRK
VCM
VPM
Royal Bank of Canada's MRK Position: Q1 2026 in Review
Royal Bank of Canada increased its Merck (MRK) stake by 0.09% in Q1 2026, buying an estimated $1.34M and bringing the position to 13,201,722 shares worth $1.59B. The position accounts for 0.28% of the portfolio, ranked #67.
Royal Bank of Canada first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.94B in Q2 2024. 3,790 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Royal Bank of Canada held 13,201,722 shares of Merck worth $1.59B as of Q1 2026.
- Royal Bank of Canada bought 11,637 Merck shares in Q1 2026, an estimated $1.34M.
- Merck made up 0.28% of Royal Bank of Canada's portfolio in Q1 2026, its #67 holding.
- Royal Bank of Canada first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Merck position peaked at $1.94B in Q2 2024.
- 3,790 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.